3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
115
Myelodysplastic Syndromes
109
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Leukemia
74
Hodgkin Disease
73
Leukemia, Lymphocytic, Chronic, B-Cell
72
Multiple Myeloma
71
Lymphoma, Non-Hodgkin
71
Lymphoma
66
Myeloproliferative Disorders
54
Graft vs Host Disease
50
Lymphoma, Follicular
49
Lymphoma, Mantle-Cell
47
Leukemia, Myeloid, Accelerated Phase
47
Lymphoma, Large B-Cell, Diffuse
46
Congenital Abnormalities
46
Leukemia, Myelomonocytic, Chronic
44
Lymphoma, B-Cell, Marginal Zone
43
Hematologic Neoplasms
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
42
Leukemia, Myeloid, Chronic-Phase
41
Burkitt Lymphoma
40
Primary Myelofibrosis
39
Blast Crisis
38
Neoplasms, Plasma Cell
37
Lymphoma, Large-Cell, Immunoblastic
32
Waldenstrom Macroglobulinemia
25
Myelodysplastic-Myeloproliferative Diseases
24
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
24
Lymphoma, T-Cell, Cutaneous
23
Interventions
apixaban
17
Dalteparin
12
Rivaroxaban
11
Heparin, Low-Molecular-Weight
8
Enoxaparin
8
Aspirin
8
Tinzaparin
6
Nadroparin
3
Fondaparinux
3
Warfarin
2
Rosuvastatin Calcium
2
Observation
2
Dabigatran
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
enoxaparin sodium
1
edoxaban
1
certoparin
1
bemiparin
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Tablets
1
Surveys and Questionnaires
1
Simvastatin
1
Platelet Transfusion
1
Phenprocoumon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Venous Thromboembolism
×
Tacrolimus
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled